A yet-to-be-named new company will house Merck’s women’s health, biosimilar and legacy drugs, providing space and resources for the pharma’s higher-growth businesses. By doing so, Merck joins other pharma companies in keeping drugs available to the general population but...
Read More
Your weekly dose of interesting tidbits from around the pharma web… Big retailers and health-care companies are using technology to improve primary care services. CVS recently announced plans to roll out 1,500 new enhanced in-store clinics over the...
Your weekly dose of interesting tidbits from around the pharma web… Health-care stocks rose after a U.S. appeals court punted on deciding whether the Affordable Care Act is unconstitutional. The decision will likely delay Supreme Court arguments on...
Your weekly dose of interesting tidbits from around the pharma web… With the major Democratic 2020 candidates campaigning on lowering drug prices, march-in rights are now back in focus as a tool to achieve that goal. Biopharmas are...
Your weekly dose of interesting tidbits from around the pharma web… HHS’ Office of Civil Rights imposed a fine on the Texas Health and Human Services Commission $1.6 million. It also fined the Rochester Medical Center $3 million...
Your weekly dose of interesting tidbits from around the pharma web… Six of the seven traditional large pharmas beat Wall Street forecasts reporting stronger-than-expected sales for the third quarter. While Eli Lilly just barely missed Wall Street expectations,...
English